These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37462205)
21. Epithelioid blue nevus: neoplasm Sui generis or variation on a theme? Groben PA; Harvell JD; White WL Am J Dermatopathol; 2000 Dec; 22(6):473-88. PubMed ID: 11190438 [TBL] [Abstract][Full Text] [Related]
22. Combined deep penetrating nevi of the conjunctiva are relatively common lesions characterised by BRAFV600E mutation and activation of the beta catenin pathway: a clinicopathological analysis of 34 lesions. Šekoranja D; Vergot K; Hawlina G; Pižem J Br J Ophthalmol; 2020 Jul; 104(7):1016-1021. PubMed ID: 31558492 [TBL] [Abstract][Full Text] [Related]
23. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi. Lohman ME; Steen AJ; Grekin RC; North JP J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032 [TBL] [Abstract][Full Text] [Related]
24. PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors. Mert M; Bozdogan O; Bozdogan N; Gamsızkan M; Safali M Am J Dermatopathol; 2024 Oct; 46(10):653-662. PubMed ID: 38916203 [TBL] [Abstract][Full Text] [Related]
25. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics. Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781 [TBL] [Abstract][Full Text] [Related]
26. The deep penetrating nevus. Strazzula L; Senna MM; Yasuda M; Belazarian L J Am Acad Dermatol; 2014 Dec; 71(6):1234-40. PubMed ID: 25175710 [TBL] [Abstract][Full Text] [Related]
27. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301 [TBL] [Abstract][Full Text] [Related]
28. Pitfalls of PRAME Immunohistochemistry in a Large Series of Melanocytic and Nonmelanocytic Lesions With Literature Review. Turner N; Ko CJ; McNiff JM; Galan A Am J Dermatopathol; 2024 Jan; 46(1):21-30. PubMed ID: 37982498 [TBL] [Abstract][Full Text] [Related]
29. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma. Oaxaca G; Billings SD; Ko JS J Cutan Pathol; 2020 Sep; 47(9):815-823. PubMed ID: 32330325 [TBL] [Abstract][Full Text] [Related]
30. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Murali R; McCarthy SW; Scolyer RA Adv Anat Pathol; 2009 Nov; 16(6):365-82. PubMed ID: 19851128 [TBL] [Abstract][Full Text] [Related]
31. Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms. McBride JD; McAfee JL; Piliang M; Bergfeld WF; Fernandez AP; Ronen S; Billings SD; Ko JS J Cutan Pathol; 2022 Mar; 49(3):220-230. PubMed ID: 34476825 [TBL] [Abstract][Full Text] [Related]
32. Preferentially expressed antigen in melanoma immunohistochemistry as an adjunct for differential diagnosis in acral lentiginous melanoma and acral nevi. Hu J; Cai X; Lv JJ; Wan XC; Zeng XY; Feng ML; Dai B; Kong YY Hum Pathol; 2022 Feb; 120():9-17. PubMed ID: 34800527 [TBL] [Abstract][Full Text] [Related]
33. PRAME immunohistochemistry is useful in differentiating oral melanomas from nevi and melanotic macules. Schmitt TA; Lee JC; Martinka M; Ko KYC J Cutan Pathol; 2023 Mar; 50(3):275-278. PubMed ID: 36398487 [TBL] [Abstract][Full Text] [Related]
34. Blue lesions. Longo C; Scope A; Lallas A; Zalaudek I; Moscarella E; Gardini S; Argenziano G; Pellacani G Dermatol Clin; 2013 Oct; 31(4):637-47, ix. PubMed ID: 24075551 [TBL] [Abstract][Full Text] [Related]
35. ALK Rearrangements Are Infrequent in Cellular Blue Nevus and Deep Penetrating Nevus. Dunn ALJ; Gardner JM; Kaley JR; Bellamy W; Shalin SC Am J Dermatopathol; 2018 Jul; 40(7):469-478. PubMed ID: 29923908 [TBL] [Abstract][Full Text] [Related]
36. Digital quantification of PRAME for distinguishing melanoma from nevi compared to manual assessment. Enevoldsen J; Brogård MB; Lade-Keller J; Christensen KB; Georgsen JB; Nielsen PS; Steiniche T Pathol Res Pract; 2024 Oct; 262():155543. PubMed ID: 39154604 [TBL] [Abstract][Full Text] [Related]
37. PRAME Expression in Melanocytic Proliferations in Special Sites. Maniaci JL; Raghavan SS Cutis; 2024 Jan; 113(1):43-47. PubMed ID: 38478941 [TBL] [Abstract][Full Text] [Related]
38. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi. Gill P; Prieto VG; Austin MT; Giubellino A; Torres-Cabala CA J Cutan Pathol; 2021 Nov; 48(11):1410-1415. PubMed ID: 34164835 [TBL] [Abstract][Full Text] [Related]
40. SF3B1 and BAP1 mutations in blue nevus-like melanoma. Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]